Interestingly, the higher migration and invasiveness in TROP2-overexpressing ATF2-KO cell lines were not associated with robust EMT signs as already shown in three different tumor entities by Remsik et al. for breast and prostate cancer [36], and Guerra et al. for colorectal cancer [20]. The gene discussed is TACSTD2; the disease is prostate cancer.